Болгарія -
болгарська -
БАБХ (Българска агенция по безопасност на храните)
cevac nd-ib-eds k
ceva sante animale - Вирус е инфекциозен бронхит (csi), на щам М-41; вирус Ньюкаслской болест (НДВ), СЗ щам Ла "пчелна пита"; яйца синдром вирус (УОВЭ), щам b8/78 - инжекционна емулсия - индуциращ мин. 6 log2 hi; индуциращ мин. 4 log2 hi или мин. 50 pd50; индуциращ мин. 7 log2 hi - кокошки
Болгарія -
болгарська -
БАБХ (Българска агенция по безопасност на храните)
cevac new k мин. 50 pd50
ceva sante animale - Вирус на нюкасълска болест (НДВ), прецедете НДВ-СЗ - инжекционна емулсия - мин. 50 pd50 - кокошки
Болгарія -
болгарська -
БАБХ (Българска агенция по безопасност на храните)
diacip
Фарма СИС БГ ООД - Диазинон, а-циперметрин - емулсия за поливане - 25 g/100 ml; 1,5 g/100 ml - говеда, овце
Європейський Союз -
болгарська -
EMA (European Medicines Agency)
vectormune fp ilt + ae
ceva-phylaxia co. ltd. - live recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus (rfp-lt) and avian encephalomyelitis virus, strain calnek 1143 (ae) - immunologicals for aves, live viral vaccines, domestic fowl - Пиле - for active immunisation of chickens of 8 to 13 weeks of age in order to reduce the skin lesions due to fowlpox, to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis and to prevent egg production losses due to avian encephalomyelitis.
Європейський Союз -
болгарська -
EMA (European Medicines Agency)
prevexxion rn+hvt+ibd
boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease virus, serotype 1, strain rn1250; live recombinant turkey herpesvirus, expressing the vp2 protein of infectious bursal disease virus, strain vhvt013-69 - immunologicals for aves, domestic fowl, avian herpes virus (marek's disease) + avian infectious bursal disease virus (gumboro disease) + newcastle disease virus/paramyxovirus - Пиле - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus), and to prevent mortality, clinical signs and lesions caused by infectious bursal disease (ibd) virus.